Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma

Konstantin Krasagakis1, Maria Metaxari, Maria Zervou

  • 1Department of Dermatology, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece. krasagak@med.uoc.gr

Anticancer Research
|April 19, 2011
PubMed
Abstract

Insights

A KIT mutation (M541L) was found in a Merkel cell carcinoma (MCC) cell line, but not in patient samples. This finding requires further investigation into the role of KIT variations in MCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive skin cancer.
  • MCC is characterized as a KIT-positive tumor.
  • The role of KIT mutations in MCC pathogenesis is largely unknown.

Purpose of the Study:

  • To investigate the presence of KIT mutations in Merkel cell carcinoma.
  • To determine if KIT mutations contribute to MCC development.

Main Methods:

  • Sequencing of the entire coding region of KIT in the MCC-1 cell line.
  • PCR amplification and sequencing of KIT exon 10 from archival MCC specimens.

Main Results:

  • A KIT exon 10 M541L sequence variation was identified in the MCC-1 cell line.
  • This variation increases sensitivity to stem cell factor.
  • KIT exon 10 sequencing in six MCC patient samples revealed wild-type sequences.

Conclusions:

  • The M541L KIT variation found in an MCC cell line warrants further research.
  • The specific role of this KIT variation in MCC pathogenesis needs to be elucidated.

Related Concept Videos